Neural Circuits Underlying Post-operative Delirium in Early Stage Alzheimer's Disease
早期阿尔茨海默病术后谵妄的神经回路
基本信息
- 批准号:10590280
- 负责人:
- 金额:$ 13.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-12-15 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdultAdvisory CommitteesAffectAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAmyloidAnesthesia proceduresAnestheticsAnimalsAttentionAttentional deficitAttenuatedAutomobile DrivingAwardBasic ScienceBehavioralBrainBrain PathologyChronicClinicalClinical ResearchCognitive deficitsCommunicationCommunitiesComplicationConfusionCuriositiesDementiaDevelopmentDevelopment PlansElderlyEnvironmentFunctional disorderGeneral AnesthesiaGeneral HospitalsGeneral anesthetic drugsGeneticGenetic TechniquesGoalsGrantHealthcareHistopathologyHospitalizationHourHumanImpairmentInterventionLeadLinear ModelsMassachusettsMediatingMentorsMentorshipNeurocognitiveNeuronsOperant ConditioningOutcomePathologicPathologyPhasePositioning AttributePostoperative ComplicationsPre-Clinical ModelRattusReaction TimeResearchResearch PersonnelRiskRodent ModelRoleSeveritiesSymptomsTechniquesTestingTherapeutic InterventionTimeTrainingTransgenic OrganismsTranslational ResearchUnconscious StateVariantVentral Tegmental AreaViralWorkWritingbehavior testbrain tissuecareercareer developmentcareer networkingclinically relevantcognitive functioncognitive recoverycognitive testingcostdopaminergic neuroninattentioninsightlocus ceruleus structuremedical schoolsmortality riskneural circuitneuropathologynoninvasive brain stimulationnoradrenergicnovelnovel therapeuticspostoperative deliriumpre-clinicalpreventprodromal Alzheimer&aposs diseaseprogramsskillsstatisticssustained attentiontau Proteinstau aggregationtherapeutic targettooltouchscreentransgenic model of alzheimer disease
项目摘要
Postoperative delirium (POD) is a common and serious postoperative complication among the elderly, especially
those with Alzheimer’s disease (AD), and has no available treatments. Interestingly, the risk for POD begins at
preclinical AD stages when mild sustained attention deficits emerge. For this K99/R00, I will investigate the role
of the locus coeruleus and ventral tegmental area – two regions affected by AD pathology and inhibited by
general anesthetics – on the development of sustained attention deficits and POD using the rodent model of AD,
TgF344-AD. I have developed a variant of the 5-choice serial reaction time task, a touchscreen sustained
attention task, in which real-time cognitive recovery is assessed in rats following general anesthesia to capture
the severity and duration of POD symptoms. In Aim 1 (K99), I will characterize the progression of sustained
attention deficits in TgF344-AD and aging rats and its association with POD and AD histopathology. In Aim 2.1
(K99), I will use a novel dual-viral mediated chemogenetic targeting technique to establish the role of ventral
tegmental area dopaminergic neurons in AD-related attentional impairments. With these skills, I will be well-
equipped to independently pursue Aim 2.2 (R00), which applies the same techniques to investigate
noradrenergic locus coeruleus neurons in AD-related attention impairments, and Aim 3 (R00), where chronic
and acute activation of the ventral tegmental area and locus coeruleus will be used to mitigate AD-associated
POD. My overall career goal is to lead an independent research group examining the underlying neural circuits
impacting POD in AD with the long-term goal of creating interventional therapeutic strategies against dementia-
associated POD. To accomplish this goal, I will need additional training in chemogenetic techniques, transgenic
rodent models of AD, and AD neuropathology. For the K99 phase, I will have the guidance of my mentor, Dr.
Ken Solt, who will train me in chemogenetics, and co-mentor, Dr. Zhongcong Xie, an expert in AD and POD
research. My Advisory Committee, Drs. Christiane Wrann (AD transgenic model expertise) and Timothy Houle
(statistics expertise), will provide research and professional guidance as I near independence. My career
development plan integrates didactics in AD pathology and neuroengineering; training in communication, lab
management, and grant writing; and professional networking opportunities. Massachusetts General Hospital and
Harvard Medical School provide the ideal environment to conduct the proposed research, providing all the
facilities necessary within a supportive, collaborative team of researchers and clinicians. The protected time and
mentorship provided by this K99/R00 will allow me to acquire the technical and conceptual skills required to lead
a focused research program on POD and AD research as an independent investigator. The outcome of this work
will yield important insight into the role of neural circuits implicated in prodromal AD and aging and how they may
be targeted to prevent and treat POD.
术后谵妄(POD)是老年人术后常见而严重的并发症,
那些患有阿尔茨海默病(AD)的人,并且没有可用的治疗方法。有趣的是,POD的风险始于
出现轻度持续注意力缺陷的临床前AD阶段。对于此K99/R 00,我将研究
蓝斑和腹侧被盖区--这两个区域受到AD病理学的影响并被抑制
全身麻醉药-使用AD啮齿动物模型对持续注意力缺陷和POD的发展,
TgF344-AD。我开发了一个5选择系列反应时间任务的变体,一个触摸屏持续
注意力任务,其中在全身麻醉后评估大鼠的实时认知恢复以捕获
POD症状的严重程度和持续时间。在目标1(K99)中,我将描述持续性
TgF 344-AD和衰老大鼠的注意缺陷及其与POD和AD组织病理学的关系。在目标2.1
(K99),我将使用一种新的双病毒介导的化学遗传靶向技术来建立腹侧的作用,
被盖区多巴胺能神经元与AD相关注意力障碍有了这些技能,我会很好-
配备独立追求目标2.2(R 00),它应用相同的技术来调查
去甲肾上腺素能蓝斑神经元在AD相关的注意力障碍,和Aim 3(R 00),其中慢性
腹侧被盖区和蓝斑的急性激活将用于减轻AD相关的
POD。我的总体职业目标是领导一个独立的研究小组,
影响AD中的POD,长期目标是创建针对痴呆症的干预性治疗策略-
相关POD为了实现这个目标,我需要在化学遗传学技术,转基因,
AD的啮齿动物模型和AD神经病理学。对于K99阶段,我将有我的导师,博士的指导。
肯·索尔特,他将在化学遗传学方面训练我,以及共同导师,谢忠聪博士,AD和POD专家
research.我的顾问委员会,Christiane Wrann博士(AD转基因模型专家)和Timothy Houle博士
(统计专业知识),将提供研究和专业指导,因为我接近独立。我的职业生涯
发展计划整合了AD病理学和神经工程学的教学法;交流,实验室
管理,并授予写作;和专业网络的机会。马萨诸塞州总医院和
哈佛医学院为开展拟议的研究提供了理想的环境,
在研究人员和临床医生的支持性协作团队中提供必要的设施。受保护的时间和
K99/R 00提供的指导将使我获得领导所需的技术和概念技能
作为一名独立的研究者,专注于POD和AD研究的研究计划。这项工作的成果
将产生重要的洞察神经回路的作用牵连在前驱AD和老化,以及他们如何可能
有针对性地防治POD。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathleen Frances Vincent其他文献
Kathleen Frances Vincent的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 13.52万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 13.52万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 13.52万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 13.52万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 13.52万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 13.52万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 13.52万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 13.52万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 13.52万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 13.52万 - 项目类别:
Research Grant














{{item.name}}会员




